Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 56 out of 100. Digital health tools

Topic: Risk, prevention and care in population studies

The reviewed studies demonstrated that wearable sensors, particularly those employing multimodal data and personalized machine learning models, enable reliable detection of agitation symptoms and support timely, tailored interventions. The concept of digital phenotyping emerged as a promising approach for capturing complex behavioral signatures, while user-centered design was identified as essential for adoption and long-term compliance. The evidence identified in this scoping review indicates that wearable and multimodal sensor technologies may offer promising approaches for monitoring agitation in dementia, while acknowledging that the research remains in early stages. We recommend future research focus on large-scale, longitudinal validation and the expansion of these tools to other populations with communication challenges, such as individuals with autism spectrum disorder or traumatic brain injury. Systematic review registration: https://doi.org/10.17605/OSF.IO/DNHYM.

Key findings

Why it matters

This scoping review found that wearable and multimodal sensor technologies may help detect agitation in dementia, but noted the research is still in early stages and needs large-scale, longitudinal validation. It concerns monitoring a symptom, not treating, curing or preventing Alzheimer's disease.

Study details

How this study scored 56/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 12 of 12; Strength of evidence 5 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 4 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record left out, no data; Institution's track record left out, no data; Multi-centre collaboration 0 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. 52 of the 93 points it could be judged on, which is 56 of 100. Total 56 of 100.52 of the 93 points we could judge = 56 of 100

Published in a peer-reviewed journal, and it is a systematic review of all the studies on the question. Scored zero for sample size, effect reported and studied in people because the record does not state it. We have no data on senior author's track record and institution's track record, so those were left out: it earned 52 of the 93 points we could judge it on, which is 56 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Frontiers in Neurology)
Journal's citation record 2 / 4 Frontiers in Neurology: journal h-index 162 (OpenAlex, 2026-10-29)
Study design 12 / 12 A systematic review of all the studies on the question
Strength of evidence 5 / 5 Rated “high” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 A review of other studies — randomisation is not credited here
Times cited 1 / 7 Cited 4 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 2.0 citations a year over 2 year(s) since 2026
Impact for its field and year 4 / 6 Cited 12.9× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 4 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 OpenAlex's profile for last-listed author Mercy Mbogori-Kairichi holds only 5 work(s), too few to judge a track record — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multi-centre collaboration 0 / 3 OpenAlex lists 0 institution(s) in 0 countries — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41743052)
Free to read 2 / 2 Free to read
Points 52 / 93 Scored on 18 of 20 parts. We have no data for the rest, so they are left out: 52 of the 93 points we could judge it on is 56 out of 100.
Total 56 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Malioukis, A., Snead, R. S., Marczika, J., Ambalavanan, R., Towett, G., & Mbogori-Kairichi, M. (2026). Digital biomarkers for early agitation detection in dementia: a scoping review of emerging wearable and smart technologies for personalized care. Frontiers in Neurology. https://doi.org/10.3389/fneur.2026.1683517

Vancouver

Malioukis A, Snead RS, Marczika J, Ambalavanan R, Towett G, Mbogori-Kairichi M. Digital biomarkers for early agitation detection in dementia: a scoping review of emerging wearable and smart technologies for personalized care. Frontiers in Neurology. 2026. doi:10.3389/fneur.2026.1683517. PMID: 41743052.

BibTeX

@article{malioukis2026-41743052,
  author  = {Malioukis, Alex and Snead, R Sterling and Marczika, Julia and Ambalavanan, Radha and Towett, Gideon and Mbogori-Kairichi, Mercy},
  title   = {{Digital biomarkers for early agitation detection in dementia: a scoping review of emerging wearable and smart technologies for personalized care}},
  journal = {Frontiers in Neurology},
  year    = {2026},
  doi     = {10.3389/fneur.2026.1683517},
  pmid    = {41743052},
  url     = {https://doi.org/10.3389/fneur.2026.1683517}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Digital health tools

Also tagged “prevalence”

1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.

Similar studies

More on Digital health tools

See all studies in Digital health tools →